Submitted by Anonymous (not verified) on 22 May 2026 - 12:25
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised